Use of fulvestrant in the treatment of resistant breast cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/565 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2403608

The invention relates to the use of fulvestrant in the treatment of breast cancer in patients who have previously been treated with an Selective Estrogen Receptor Modulator (SERM) and an aromatase inhibitor.

L'invention concerne l'utilisation de fulvestrant dans le traitement du cancer du sein chez des patients ayant préalablement été traités par un modulateur sélectif des récepteurs d'oestrogènes (SERM) et un inhibiteur d'aromatase.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of fulvestrant in the treatment of resistant breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of fulvestrant in the treatment of resistant breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of fulvestrant in the treatment of resistant breast cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1676407

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.